GSTM1 is also the primary enzyme handling oxidative stress byproducts from CYP1A1/CYP1B1-mediated estrogen metabolism including reactive oxygen species generated during the hydroxylation reactions themselves
Miyata M, Yoshihisa A, Yamauchi H, et al
Plant J 41:1530 Wang CL, Oliver DJ (1996) Cloning of the cDNA and genomic clones for glutathione synthetase from Arabidopsis thaliana and complementation of a gsh2 mutant in fission yeast
Plan for after the medication GLP-1 medications are tools, not permanent solutions for everyone
Up to now, we don't know, or there havent been specific reports of direct impacts on patients with NETs, but there are some theoretical suggestions that these agents could have impact on some [of these] patients
Who Should Not Take GLP-1